Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Andrew Spencer

Corresponding Author: Andrew Spencer

Head of Malignant Haematology & Stem Cell Transplantation Service and Myeloma Research Group

Ground Floor

South Block

Australia

[email]@netspace.net.au

Name/email consistency: high

[Claim this account]

Affiliations

Corresponding Author: Andrew Spencer, Head of Malignant Haematology & Stem Cell Transplantation Service and Myeloma Research Group, Ground Floor, South Block, Australia. 2011
Malignant Haematology and Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Victoria, Australia. 2004 - 2009
Clinical Haematology and BMT, Alfred Hospital, and Myeloma Research Group, Alfred Hospital, Australia. 2007

References

Targeting HSP 90 Induces Apoptosis and Inhibits Critical Survival and Proliferation Pathways in Multiple Myeloma. Khong, T., Spencer, A. Mol. Cancer Ther. (2011) [Pubmed]
Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure. Spencer, A., Prince, H.M., Roberts, A.W., Prosser, I.W., Bradstock, K.F., Coyle, L., Gill, D.S., Horvath, N., Reynolds, J., Kennedy, N. J. Clin. Oncol. (2009) [Pubmed]
Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study. Spencer, A., Roberts, A., Kennedy, N., Ravera, C., Cremers, S., Bilic, S., Neeman, T., Copeman, M., Schran, H., Lynch, K. BMC. Clin. Pharmacol (2008) [Pubmed]
Pilot study of an outpatient-based approach for advanced lymphoma using vinorelbine, gemcitabine and filgrastim. Spencer, A., Reed, K., Arthur, C. Intern. Med. J (2007) [Pubmed]
Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation. Spencer, A., Horvath, N., Gibson, J., Prince, H.M., Herrmann, R., Bashford, J., Joske, D., Grigg, A., McKendrick, J., Prosser, I., Lowenthal, R., Deveridge, S., Taylor, K. Bone Marrow Transplant. (2005) [Pubmed]
Induction with oral chemotherapy (CID) followed by early autologous stem cell transplantation for de novo multiple myeloma patients. Spencer, A., Seldon, M., Deveridge, S., Cobcroft, R., Cull, G., Marlton, P., Enno, A., Gill, D. Hematol. J. (2004) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.